Table 2.
Patient | Age | Stagea | Pathology | Tumor | Response to | Time | Metastatic | HPV | Relative |
Code | Type | Size | Radiotherapy | Recur | Organ | type | amount of | ||
(cm) | (month)b | E6:ZP3 | |||||||
PCRf | |||||||||
4 | 39 | IIB | Adenomatous | 7 | Partial | 18 | 0.02 | ||
148 | 65 | IIB | Squamous | 3 | Complete | 8 | Pleura, | 18 | 0.04 |
Peritoneumc | |||||||||
183 | 27 | IIB | Squamous | 6 | Partial | 11 | Bone c | 18 | 0.05 |
106 | 51 | IVB | Squamous | >4 | Liver, Pleurad | 18 | 0.14 | ||
161 | 34 | Re | Squamous | 7 | Umbillicus d | 16 | 0.19 | ||
59 | 46 | Re | Squamous | 5 | Liver, Lung d | 16 | 0.05 |
a Stage at the time of blood examination; bTime for recurrence after complete treatment; c Metastasis at time of recurrence; d Metastasis at time of plasma DNA analysis; e R, recurrence; f Average amount from two experiments